Publication | Open Access
A genetic modifier of symptom onset in Pompe disease
45
Citations
32
References
2019
Year
c.510C>T is a genetic modifier in compound heterozygous and homozygous IVS1 patients. This finding is important for neonatal screening programs for Pompe disease. FUND: This work was funded by grants from Sophia Children's Hospital Foundation (SSWO, grant S17-32) and Metakids (2016-063).
| Year | Citations | |
|---|---|---|
Page 1
Page 1